+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Percutaneous Nephrolithotomy Global Market Report 2024

  • PDF Icon

    Report

  • 175 Pages
  • August 2024
  • Region: Global
  • The Business Research Company
  • ID: 5990969
Percutaneous nephrolithotomy (PCNL) is a minimally invasive surgical procedure used to remove kidney stones (renal calculi) from the urinary tract. This procedure involves making a small incision in the skin and creating a direct channel to the kidney through which instruments are inserted to break up and extract the stones. PCNL is employed when other less invasive methods, such as shock wave lithotripsy or ureteroscopy, are ineffective or unsuitable.

The main types of kidney stones treated by percutaneous nephrolithotomy include magnesium ammonium phosphate stones, calcareous stones, and uric acid calculi. Magnesium ammonium phosphate (MAP) stones are composed of magnesium, ammonium, and phosphate ions. The components involved in PCNL include accessories, devices, and services, which are utilized by end users such as ambulatory surgical centers, clinics, and hospitals.

The percutaneous nephrolithotomy market research report is one of a series of new reports that provides percutaneous nephrolithotomy market statistics, including the percutaneous nephrolithotomy industry global market size, regional shares, competitors with percutaneous nephrolithotomy market share, detailed percutaneous nephrolithotomy market segments, market trends, and opportunities, and any further data you may need to thrive in the percutaneous nephrolithotomy industry. These percutaneous nephrolithotomy market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The percutaneous nephrolithotomy market size has grown strongly in recent years. It will grow from $16.49 billion in 2023 to $17.9 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth observed in the historic period can be attributed to several factors, including the increasing prevalence of kidney stones, rising demand for effective and efficient treatment options for kidney stones, expansion of healthcare infrastructure in emerging economies, an aging population leading to a higher incidence of kidney stones, a surge in research and development activities, increasing healthcare expenditure, and a growing emphasis on patient-centric healthcare.

The percutaneous nephrolithotomy market size is expected to see strong growth in the next few years. It will grow to $25.15 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The expected growth in the forecast period can be attributed to several factors, including the growing adoption of minimally invasive surgical procedures, rising demand for effective stone removal techniques, increasing awareness about the benefits of percutaneous nephrolithotomy, a growing geriatric population prone to kidney stone formation, the increasing availability of advanced medical technologies for stone removal, a rising focus on patient-centric care, and an increasing preference for outpatient procedures. Major trends anticipated during this period include the adoption of miniaturized instruments, advancements in imaging technologies, implementation of robotics, adoption of disposable devices, advancements in stone retrieval devices, improvements in anesthesia techniques, implementation of enhanced infection control measures, adoption of multimodal pain management, and the development of training programs.

The increasing prevalence of renal diseases is set to drive the growth of the percutaneous nephrolithotomy market in the coming years. Renal diseases encompass a variety of conditions affecting the kidneys and hindering their proper functioning. Factors contributing to the prevalence of renal diseases include rising rates of diabetes and hypertension, an aging population, lifestyle choices, genetic factors, chronic conditions, and improved awareness and diagnosis. Percutaneous nephrolithotomy plays a crucial role in managing renal diseases by offering a minimally invasive surgical procedure to remove large or complex kidney stones, alleviate pain, prevent urinary tract infections, and enhance kidney function. For example, a UK-based Kidney Research Commission reported in June 2023 that kidney disease affected 7.19 million people in the UK in 2023 and is projected to increase to 7.61 million by 2033. Hence, the increasing prevalence of renal diseases is fueling growth in the percutaneous nephrolithotomy market.

Leading companies in the percutaneous nephrolithotomy market are concentrating on implementing innovative solutions, such as robot-assisted surgical platforms, to improve surgical precision and patient outcomes. A robot-assisted surgical platform is an advanced medical system utilizing robotic technology to aid surgeons in performing complex procedures with enhanced precision, control, and flexibility. For instance, Ethicon Inc., a US-based Johnson & Johnson MedTech company, announced in February 2023 the successful robotic-assisted removal of kidney stones in the first patient using the MONARCH Platform for urology. This platform enables urologists to navigate the kidney with robotic assistance, facilitating access, clearance, and control via a handheld controller. It offers a unified platform supporting ureteroscopic and percutaneous nephrolithotomy (PCNL) procedures, delivering enhanced navigation, access, clearance, and control compared to traditional methods.

In March 2021, Boston Scientific, a US-based medical device manufacturing company, acquired Lumenis Ltd. The acquisition aims to bolster Boston Scientific's presence in the global surgical market, particularly in urology and otolaryngology procedures. Additionally, it incorporates Lumenis' innovative MOSES technology, known for improving clinical outcomes in kidney stone management. Lumenis Ltd. is an Israel-based energy-based medical device company specializing in developing and manufacturing laser and light-based systems for various medical applications, including percutaneous nephrolithotomy (PCNL).

Major companies operating in the percutaneous nephrolithotomy market are Boston Scientific Corporation, Zimmer Biomet Holdings Inc., Olympus Corporation, Terumo Corporation, Coloplast Corporation, B. Braun, Cook Medical, Teleflex Incorporated, Karl Storz Se And Co. KG, Merit Medical Systems, Richard Wolf GmbH, AngioDynamics, Argon Medical Devices, Dornier MedTech, EDAP TMS, Allengers Medical Systems Limited, DirexGroup, Envaste Limited, ELMED Lithotripsy Systems, PolyDiagnost, Attikouris Enterprises Ltd., Advin Urology, Avenda Health, Guangzhou Potent Optotronic Technology Co. Ltd., Surgimedik.

North America was the largest region in the percutaneous nephrolithotomy market in 2023. The regions covered in the percutaneous nephrolithotomy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the percutaneous nephrolithotomy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The percutaneous nephrolithotomy market consists of revenues earned by entities by providing services such as preoperative consultation and assessment, imaging services, anesthesia services, and postoperative care. The market value includes the value of related goods sold by the service provider or included within the service offering. The percutaneous nephrolithotomy market also includes sales of nephroscopes, lithotripters, and guidewires. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Percutaneous Nephrolithotomy Market Characteristics3. Percutaneous Nephrolithotomy Market Trends And Strategies
4. Percutaneous Nephrolithotomy Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Percutaneous Nephrolithotomy Market Size and Growth
5.1. Global Percutaneous Nephrolithotomy Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Percutaneous Nephrolithotomy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Percutaneous Nephrolithotomy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Percutaneous Nephrolithotomy Market Segmentation
6.1. Global Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Magnesium Ammonium Phosphate Stone Type
  • Calcareous Type
  • Uric Acid Calculi Type
6.2. Global Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Accessories
  • Devices
  • Services
6.3. Global Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Ambulatory Surgical Centers
  • Clinics
  • Hospitals
7. Percutaneous Nephrolithotomy Market Regional And Country Analysis
7.1. Global Percutaneous Nephrolithotomy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Percutaneous Nephrolithotomy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Percutaneous Nephrolithotomy Market
8.1. Asia-Pacific Percutaneous Nephrolithotomy Market Overview
(Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies)
8.2. Asia-Pacific Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Percutaneous Nephrolithotomy Market
9.1. China Percutaneous Nephrolithotomy Market Overview
9.2. China Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Percutaneous Nephrolithotomy Market
10.1. India Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Percutaneous Nephrolithotomy Market
11.1. Japan Percutaneous Nephrolithotomy Market Overview
11.2. Japan Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Percutaneous Nephrolithotomy Market
12.1. Australia Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Percutaneous Nephrolithotomy Market
13.1. Indonesia Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Percutaneous Nephrolithotomy Market
14.1. South Korea Percutaneous Nephrolithotomy Market Overview
14.2. South Korea Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Percutaneous Nephrolithotomy Market
15.1. Western Europe Percutaneous Nephrolithotomy Market Overview
15.2. Western Europe Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Percutaneous Nephrolithotomy Market
16.1. UK Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Percutaneous Nephrolithotomy Market
17.1. Germany Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Percutaneous Nephrolithotomy Market
18.1. France Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Percutaneous Nephrolithotomy Market
19.1. Italy Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Percutaneous Nephrolithotomy Market
20.1. Spain Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Percutaneous Nephrolithotomy Market
21.1. Eastern Europe Percutaneous Nephrolithotomy Market Overview
21.2. Eastern Europe Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Percutaneous Nephrolithotomy Market
22.1. Russia Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Percutaneous Nephrolithotomy Market
23.1. North America Percutaneous Nephrolithotomy Market Overview
23.2. North America Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Percutaneous Nephrolithotomy Market
24.1. USA Percutaneous Nephrolithotomy Market Overview
24.2. USA Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Percutaneous Nephrolithotomy Market
25.1. Canada Percutaneous Nephrolithotomy Market Overview
25.2. Canada Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Percutaneous Nephrolithotomy Market
26.1. South America Percutaneous Nephrolithotomy Market Overview
26.2. South America Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Percutaneous Nephrolithotomy Market
27.1. Brazil Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Percutaneous Nephrolithotomy Market
28.1. Middle East Percutaneous Nephrolithotomy Market Overview
28.2. Middle East Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Percutaneous Nephrolithotomy Market
29.1. Africa Percutaneous Nephrolithotomy Market Overview
29.2. Africa Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Percutaneous Nephrolithotomy Market Competitive Landscape And Company Profiles
30.1. Percutaneous Nephrolithotomy Market Competitive Landscape
30.2. Percutaneous Nephrolithotomy Market Company Profiles
30.2.1. Boston Scientific Corporation
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Zimmer Biomet Holdings Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Olympus Corporation
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Terumo Corporation
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Coloplast Corporation
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Percutaneous Nephrolithotomy Market Other Major And Innovative Companies
31.1. B. Braun
31.2. Cook Medical
31.3. Teleflex Incorporated
31.4. Karl Storz Se And Co. KG
31.5. Merit Medical Systems
31.6. Richard Wolf GmbH
31.7. AngioDynamics
31.8. Argon Medical Devices
31.9. Dornier MedTech
31.10. EDAP TMS
31.11. Allengers Medical Systems Limited
31.12. DirexGroup
31.13. Envaste Limited
31.14. ELMED Lithotripsy Systems
31.15. PolyDiagnost
32. Global Percutaneous Nephrolithotomy Market Competitive Benchmarking33. Global Percutaneous Nephrolithotomy Market Competitive Dashboard34. Key Mergers And Acquisitions In The Percutaneous Nephrolithotomy Market
35. Percutaneous Nephrolithotomy Market Future Outlook and Potential Analysis
35.1 Percutaneous Nephrolithotomy Market In 2028 - Countries Offering Most New Opportunities
35.2 Percutaneous Nephrolithotomy Market In 2028 - Segments Offering Most New Opportunities
35.3 Percutaneous Nephrolithotomy Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright And Disclaimer

Executive Summary

Percutaneous Nephrolithotomy Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on percutaneous nephrolithotomy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for percutaneous nephrolithotomy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The percutaneous nephrolithotomy market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Magnesium Ammonium Phosphate Stone Type; Calcareous Type; Uric Acid Calculi Type
2) By Component: Accessories; Devices; Services
3) By End-User: Ambulatory Surgical Centers; Clinics; Hospitals

Key Companies Mentioned: Boston Scientific Corporation; Zimmer Biomet Holdings Inc.; Olympus Corporation; Terumo Corporation; Coloplast Corporation

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Boston Scientific Corporation
  • Zimmer Biomet Holdings Inc.
  • Olympus Corporation
  • Terumo Corporation
  • Coloplast Corporation
  • B. Braun
  • Cook Medical
  • Teleflex Incorporated
  • Karl Storz Se And Co. KG
  • Merit Medical Systems
  • Richard Wolf GmbH
  • AngioDynamics
  • Argon Medical Devices
  • Dornier MedTech
  • EDAP TMS
  • Allengers Medical Systems Limited
  • DirexGroup
  • Envaste Limited
  • ELMED Lithotripsy Systems
  • PolyDiagnost
  • Attikouris Enterprises Ltd.
  • Advin Urology
  • Avenda Health
  • Guangzhou Potent Optotronic Technology Co. Ltd.
  • Surgimedik

Methodology

Loading
LOADING...